Vanguard Group Inc Talis Biomedical Corp Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.44 - $0.54 $2,239 - $2,748	-5,090 Reduced 1.08%	466,336 $223,000
Q1 2023 May 15, 2023	SELL	$0.48 - $0.64 $10,912 - $14,550	-22,735 Reduced 4.6%	471,426 $230,000
Q4 2022 Feb 10, 2023	SELL	$0.45 - $11.67 $4,916 - $127,494	-10,925 Reduced 2.16%	494,161 $222,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $10.79 $33,800 - $521,016	-48,287 Reduced 8.73%	505,086 $344,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.44 $47,837 - $85,044	-59,059 Reduced 9.64%	553,373 $450,000
Q1 2022 May 13, 2022	SELL	$1.3 - $4.19 $146,511 - $472,217	-112,701 Reduced 15.54%	612,432 $864,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.17 $595,792 - $964,839	156,376 Added 27.49%	725,133 $2.91 Million
Q3 2021 Nov 12, 2021	BUY	$6.02 - $12.46 $143,583 - $297,183	23,851 Added 4.38%	568,757 $3.56 Million
Q2 2021 Aug 13, 2021	BUY	$9.62 - $14.56 $5.24 Million - $7.93 Million	544,906 New	544,906 $6.01 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.